Detection of Carcinogenic Compounds and Toxins

• What is tested:
  - Carcinogenic metabolites formed with digestion disorders and bacterial imbalance.
  - Bacterial toxins such as exotoxins from Clostridium difficile and other pathogens.
  - Biomarkers of oxidative stress and mutagenic compounds that can damage intestinal cells.
  


• Methods used:
  - Chemical analysis with high-sensitivity mass spectrometry or chromatography to identify carcinogens.
  - Immunoassays and molecular biology techniques to detect bacterial toxins.
  - Fecal DNA tests to identify mutations linked to colorectal cancer risk.
  


• Clinical significance:
  - Early detection of colorectal cancer risk and precancerous conditions.
  - Assessment of carcinogen impact from diet (e.g., high red and processed meat intake).
  - Monitoring bacterial toxins that may worsen inflammation and infections.
  


• Indications:
  - Patients at risk for intestinal cancers, including family history and chronic inflammation.
  - Symptoms of chronic intestinal inflammation and suspected dysbiosis.
  - Post-treatment monitoring for recurrence or complications.
  


• Preparation:
  - Collect stool in a clean, sterile container without urine or water.
  - Avoid antibiotics, antimicrobials, and microbiota-affecting drugs days before the test (consult your doctor).
  - Follow dietary recommendations if provided.
  


• Result interpretation:
  - Elevated carcinogens and toxins may indicate increased colorectal cancer risk, requiring further diagnostics.
  - Presence of bacterial toxins suggests dysbiosis or infection requiring treatment.
  - Absence of significant levels reduces likelihood of complications and risks.
  


• Summary:
  This fecal test is a vital tool for early detection and prevention of oncological and inflammatory bowel diseases. It helps uncover hidden risks and optimizes management, especially in high-risk patients.

Blood

Blood

Stool

Urine